Executive Summary
Across the 8 filings in the USA S&P 500 Technology stream, dominant themes include advancing SPAC de-SPAC mergers (AParadise with Enhanced Games, dMY Squared with Horizon Quantum) and bank-tech adjacent mergers (Community West Bancshares), alongside restructuring at PSQ Holdings with strong revenue growth but cash burn, proxy preparations at Altimmune, and shelf registration post-divestitures at Planet Green. Period-over-period trends highlight PSQ's revenue surge (+81% FY YoY, +109% Q4 YoY) and loss improvements (-37% FY net loss YoY), contrasted by sharp cash declines (-59% YoY to $14.6M) and equity drops (-50% to $13.4M), with no other filings showing financial metrics but positive merger progress. Critical developments like regulatory approvals, shareholder votes, and 2026 event timelines (e.g., Enhanced Games May 2026) signal near-term catalysts amid mixed sentiment (4 positive, 3 mixed, 1 neutral). Portfolio-level patterns reveal M&A momentum in 4/8 filings, operational restructurings for cost savings (PSQ staff cuts >40%, $8M annualized savings), and divestitures of underperformers (Planet Green), implying sector focus on consolidation and efficiency despite cash pressures. Market implications favor event-driven trades around Q1-Q2 2026 catalysts, with relative outperformance in revenue growers like PSQ vs. stagnant peers.
Tracking the trend? Catch up on the prior S&P 500 Technology Sector SEC Filings digest from March 16, 2026.
Investment Signals(12)
- AParadise Acquisition Corp.β(BULLISH)β²
SPAC advancing $1.3B merger with Enhanced Games, inaugural event May 2026 in Las Vegas, arbitrage fund discloses long position in shares/rights, positive sentiment
- AParadise Acquisition Corp.β(BULLISH)β²
Enhanced Games Medical Program as clinical study with SSMC Hospital, athlete training in Abu Dhabi, tailor-made super suits, originated 2.5 years ago, no financial declines noted
- Community West Bancsharesβ(BULLISH)β²
Received FDIC, California DFPI, and Fed waiver for merger with United Security Bancshares, shareholder meetings March 30 2026, closing Q2 2026
- PSQ Holdings (8-K)(BULLISH)β²
Q4 2025 revenue +109% YoY to $7.3M, FY revenue +81% YoY to $18.2M, op ex -11% Q4/-21% FY, net losses improved -43% Q4/-37% FY
- PSQ Holdings (10-K)(BULLISH)β²
FY 2025 revenue +81% YoY to $18.2M driven by $5.6M payments/$3.3M leases, op loss -23% YoY to $32.0M, non-GAAP op loss improved to $9.1M from $1.1M, EPS -0.81 vs -1.80
- dMY Squared Technology Groupβ(BULLISH)β²
Overwhelming shareholder approval for Business Combination with Horizon Quantum (2.17M For vs 65k Against), all 7 advisory proposals passed with >99% support
- PSQ Holdingsβ(BULLISH)β²
Restructuring with Marketplace wind-down, Brands divestiture, staff cuts >40% for $8M annualized cash savings, cash position $16.1M supports path to profitability
- Altimmune, Inc.β(NEUTRAL-BULLISH)β²
Proxy seeks approval for director elections, auditor ratification, exec comp vote, share increases for ESPP/certificate amendment ahead of April 16 2026 AGM
- Planet Green Holdingsβ(NEUTRAL)β²
S-3 shelf for future offerings post-restructuring (divestitures of Allinyson/Jilin/Shandong due to losses), recent equity transfers in Hubei/Dingfeng entities
- Community West Bancsharesβ(BULLISH)β²
Joint proxy/prospectus available on SEC sites, advances previously announced merger with minimal noted risks beyond shareholder vote
- dMY Squaredβ(BULLISH)β²
Business Combination Agreement Sept 9 2025 approved post-Feb 17 2026 proxy, strong Class A/B share capital structure (40M total authorized)
- PSQ Holdingsβ(BULLISH)β²
Total costs/expenses -3% YoY to $50.2M despite revenue surge, revolving credit up to $6.2M from $3.8M signals managed liquidity
Risk Flags(10)
- PSQ Holdings/Cash Burnβ[HIGH RISK]βΌ
Cash equivalents -59% YoY to $14.6M from $35.7M, operating cash burn $19.9M FY 2025, total assets -20% YoY to $59.7M
- PSQ Holdings/Equity Declineβ[HIGH RISK]βΌ
Stockholders' equity -50% YoY to $13.4M from $26.9M, restricted cash steady at $1.1M but overall liquidity strained
- PSQ Holdings/Discontinued Opsβ[MEDIUM RISK]βΌ
Q4 discontinued losses worsened to $4.5M from $2.7M YoY, tied to Marketplace wind-down and Brands divestiture
- Planet Green Holdings/Divestituresβ[HIGH RISK]βΌ
Multiple underperforming unit sales/terminations (Allinyson Apr 2024 losses, Jilin Dec 2024, Shandong Sep 2025), no PRC subsidiary dividends to date
- Planet Green Holdings/Restructuringβ[MEDIUM RISK]βΌ
Recent equity transfers (Hubei Bulaisi/Jan 2026) amid operational underperformance, shelf registration signals potential dilution
- Community West Bancshares/Merger Risksβ[MEDIUM RISK]βΌ
Potential shareholder rejection at March 30 2026 meetings, integration delays, dilution from new shares despite regulatory approvals
- PSQ Holdings/Debt Increaseβ[MEDIUM RISK]βΌ
Revolving line of credit +63% to $6.2M from $3.8M as of Dec 31 2025, amid net losses
- Altimmune, Inc./Dilutionβ[LOW-MEDIUM RISK]βΌ
Proxy seeks certificate amendment to increase authorized shares and ESPP reserves, 130M shares outstanding record date Mar 13 2026
- PSQ Holdings/Relative Performanceβ[MEDIUM RISK]βΌ
Revenue growth strong but costs dipped only 3% YoY vs 81% revenue surge, non-GAAP op loss widened directionally
- Planet Green/Shelf Dilutionβ[HIGH RISK]βΌ
Unspecified securities registration (File No. 333-294386) post-10-K/10-Q incorporation, history of name changes and segment shifts
Opportunities(10)
- AParadise Acquisition/Enchanced Games Launchβ(OPPORTUNITY)β
$1.3B SPAC combo, Las Vegas event May 2026 (groundbreaking late Apr), free tickets/musical acts, athlete super suits/training
- dMY Squared/Horizon Quantum Mergerβ(OPPORTUNITY)β
Fresh shareholder approval March 17 2026, quantum tech focus in SPAC, minimal opposition positions for quick close
- PSQ Holdings/Restructuring Savingsβ(OPPORTUNITY)β
>40% staff cuts for $8M annualized savings, revenue +81% YoY from payments/leases, path to breakeven with $16.1M cash
- Community West Bancshares/Merger Closeβ(OPPORTUNITY)β
Regulatory approvals secured, Q2 2026 closing post-Mar 30 shareholder votes, proxy available for diligence
- Altimmune/AGM Catalystsβ(OPPORTUNITY)β
April 16 2026 virtual AGM approvals for shares/governance, record date Mar 13, potential for positive exec comp vote
- PSQ Holdings/Revenue Diversificationβ(OPPORTUNITY)β
New streams $5.6M payments +$3.3M leases drove +81% FY growth, outperforms legacy $10.1M base
- AParadise/Arbitrage Playβ(OPPORTUNITY)β
Accelerate Arbitrage Fund long shares/rights disclosure amid merger hype, PED-enabled games addressing athlete comp/health
- Planet Green/Shelf Flexibilityβ(OPPORTUNITY)β
Post-divestiture clean-up enables future capital raises for tea/chemicals/advertising, North America/China exposure
- dMY Squared/Shareholder Mandateβ(OPPORTUNITY)β
99%+ approval on org docs, 40M authorized shares supports post-merger quantum scaling
- PSQ Holdings/Loss Convergenceβ(OPPORTUNITY)β
Net loss per share -55% to ($0.81) from ($1.80), op loss -23% sets up turnaround vs peers
Sector Themes(6)
- SPAC De-SPAC Momentumβ
3/8 filings (AParadise x2, dMY Squared) show merger progress with approvals/votes, positive sentiment, May/Q2 2026 catalysts vs stagnant peers [IMPLICATION: Event-driven upside in quantum/sports-tech hybrids]
- Revenue Growth Amid Restructuringβ
PSQ (2 filings) +81-109% YoY revenue with -21% op ex cuts/$8M savings, Planet Green divestitures mirror efficiency push in 2/8 [IMPLICATION: Turnaround alpha in cash-burn normalizers]
- Cash/Liquidity Pressuresβ
PSQ cash -59% YoY to $14.6M/equity -50%, Planet no dividends, contrasts merger cash inflows; 3/8 mixed/neutral sentiment tied to burn [IMPLICATION: Monitor dilution risks in small-cap tech adjacents]
- M&A Regulatory Tailwindsβ
Community West approvals (FDIC/Fed waiver), dMY votes passed >99%, AParadise advancing; 4/8 filings M&A-focused [IMPLICATION: Consolidation boosts scale in tech/services]
- Forward Event Density Q1-Q2 2026β
Shareholder meetings (Mar 30), AGMs (Apr 16), Games launch (May), closings (Q2); 5/8 with timelines [IMPLICATION: High catalyst turnover for options/vol plays]
- Mixed Sentiment on Ops Metricsβ
Positive on mergers/revenue (5/8), mixed on PSQ/Planet cash/divestitures (3/8), no margin compression but loss improvements in growers [IMPLICATION: Favor revenue outperformers over balance sheet weaklings]
Watch List(8)
Track Las Vegas groundbreaking late Apr 2026, May 2026 Games debut for execution risks [Post-Mar 2026]
Monitor Mar 30 2026 approval meetings for merger with USB, Q2 close implications [Mar 30 2026]
Watch Marketplace wind-down/Brands divestiture, cash burn vs $8M savings realization [Q2 2026]
April 16 2026 virtual meeting for share increases/exec comp vote, proxy mailed ~Mar 19 [Apr 16 2026]
Horizon Quantum integration post-Mar 17 approval, any redemption/closing updates [Q2 2026]
Potential offerings post-S-3 effective (File 333-294386), further divestiture impacts [Ongoing 2026]
$14.6M cash +$6.2M revolver vs $19.9M burn, debt covenant/raise signals [Q1-Q2 2026]
Accelerate Fund position changes amid Enhanced Games hype, athlete sign-ups [Mar-May 2026]
Filing Analyses(8)
17-03-2026
A Paradise Acquisition Corp., a SPAC, is merging with Enhanced, an innovative sports company launching the Enhanced Games that permit FDA-approved performance-enhancing substances under medical supervision to prioritize athlete health, safety, and higher compensation compared to traditional athletics. CEO Max Martin discusses overcoming PED stigma, the Enhanced Games Medical Program run as a clinical study in Abu Dhabi with SSMC Hospital, and benefits for both elite and returning athletes. Accelerate Arbitrage Fund discloses a long position in A Paradise Acquisition shares and rights.
- Β·Enhanced Games idea originated roughly 2.5 years ago.
- Β·Athletes receive comprehensive baseline assessments and continuous medical screenings as part of the Medical Program.
- Β·Focus on two athlete types: prime athletes aiming to break records and older athletes (e.g., mid-30s) seeking personal bests.
17-03-2026
A Paradise Acquisition Corp. announced a $1.3B business combination with The Enhanced Games in November, as discussed in a SPAC Insider Podcast interview with CEO Maximilian Martin. Martin detailed the company's origins from Bitfield (acquired in late 2021), its vision to integrate legal performance-enhancing substances into athletics for better athlete compensation and health, and preparations for the inaugural Enhanced Games debut in May 2026 in Las Vegas with free tickets and musical acts. No financial declines or flat metrics were mentioned.
- Β·Enhanced Games venue construction in Las Vegas to take 4 weeks, with groundbreaking in late April 2026.
- Β·Athletes training at Earth sports and wellness complex in Abu Dhabi with custom facilities.
- Β·Tailor-made super suits provided to athletes, similar to those used in 2008-2009 swimming.
- Β·Christian Golomiev broke a 16-year world record in the pool under clinical supervision one year ago.
17-03-2026
PSQ Holdings reported Q4 2025 net revenue from continuing operations of $7.3M, up 109% YoY, and full-year revenue of $18.2M, up 81% YoY, with operating expenses down 11% in Q4 and 21% for the year. Net losses improved to $11.8M in Q4 (43% better) and $36.6M for the year (37% better), though discontinued operations losses worsened to $4.5M in Q4 from $2.7M. The company is restructuring by winding down its Marketplace segment, pursuing Brands divestiture, and cutting staff by over 40% for ~$8M annualized cash savings, amid a cash position of $16.1M.
- Β·Cash and cash equivalents: $14.6M as of Dec 31, 2025 (down from $35.7M in 2024)
- Β·Restricted cash: $1.1M as of Dec 31, 2025
- Β·Total assets declined to $59.7M from $74.9M YoY
- Β·Q4 loss per share: $0.25 (vs $0.66 prior year)
- Β·FY loss per share: $0.81 (vs $1.80 prior year)
- Β·Expected Brands segment sale agreement in H1 2026
- Β·Conference call on March 17, 2026 at 9:00 a.m. ET
17-03-2026
Altimmune, Inc. issued a proxy statement for its 2026 Annual Meeting on April 16, 2026, seeking approval for electing nine directors, ratifying Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026, an advisory vote on named executive officer compensation, amending the certificate of incorporation to increase authorized common shares, amending the 2019 ESPP to increase reserved shares, and authorizing adjournment if needed. The record date is March 13, 2026, with 130,105,177 shares of common stock outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are disclosed in the filing.
- Β·Annual Meeting held virtually at https://www.cstproxy.com/altimmune/2026 at 8:30 a.m. Eastern Time
- Β·Common Stock par value $0.0001 per share
- Β·Proxy materials first mailed on or about March 19, 2026
- Β·Company address: 910 Clopper Road, Suite 201S, Gaithersburg, Maryland 20878
17-03-2026
PSQ Holdings, Inc. reported net revenues of $18.2M for the year ended December 31, 2025, surging 81% YoY from $10.1M, fueled by new revenue streams including $5.6M in payment processing and $3.3M in lease merchandise. While operating loss narrowed 23% to $32.0M from $41.7M and net loss improved 37% to $36.6M from $57.7M, total costs and expenses dipped only 3% to $50.2M, cash and equivalents declined sharply to $14.6M from $35.7M, and stockholders' equity fell to $13.4M from $26.9M amid continued operating cash burn of $19.9M.
- Β·Non-GAAP operating loss improved to $9.1M in 2025 from $1.1M in 2024.
- Β·Revolving line of credit balance increased to $6.2M as of Dec 31 2025 from $3.8M.
- Β·Net loss per common share improved to ($0.81) from ($1.80).
- Β·Filing date: March 17, 2026.
17-03-2026
On March 17, 2026, dMY Squared Technology Group, Inc. held a virtual special shareholder meeting approving the Business Combination Proposal with Horizon Quantum Holdings Ltd. and related entities, with 2,167,706 votes For, 65,194 Against, and 380 Abstentions. All seven Advisory Organizational Documents Proposals also passed overwhelmingly, with For votes ranging from 2,164,645 to 2,230,810 and minimal opposition. No declines or flat performance noted in voting results.
- Β·Business Combination Agreement dated September 9, 2025
- Β·Definitive proxy statement filed February 17, 2026
- Β·DMY authorized share capital: 40,000,000 shares of DMY Common Stock (35,000,000 Class A, 5,000,000 Class B) and 1,000,000 shares of DMY Preferred Stock
- Β·Transactions include Holdco conversion to public company, Amalgamation of Merger Sub 1 and Horizon, and SPAC Merger of Merger Sub 2 and DMY
17-03-2026
Planet Green Holdings Corp., a Nevada holding company focused on tea products, chemical products, and online advertising services in China and North America, filed an S-3 shelf registration statement on March 17, 2026 (File No. 333-294386) to register unspecified securities for future offerings. The prospectus incorporates by reference recent SEC filings including the 10-K for FY 2024 and 10-Qs through Q3 2025, while disclosing divestitures of underperforming subsidiaries such as Allinyson (April 2024 due to recurring losses), Jilin Chuangyuan VIE termination (December 11, 2024, due to operational and financial underperformance), and Shandong Yunchu (discontinued April 30, 2025, with equity disposal September 1, 2025). Recent restructuring includes equity transfers involving Hubei Bulaisi, Dingfeng Technology, Xianning Bozhuang, and Hubei Shengsili as of January 20, 2026, with no dividends paid from PRC subsidiaries to date.
- Β·Company incorporated February 4, 1986; reincorporated in Nevada November 12, 2009; formerly American Lorain Corporation.
- Β·Fiscal year end: December 31.
- Β·Headquartered at 130-30 31st Ave, Suite 512, Flushing, NY 11354; phone (347) 370-2352.
- Β·EIN: 870430320; SIC: 2030 (Canned, Frozen & Preserved Fruit, Veg & Food Specialties).
- Β·No cash management policies; potential PRC foreign exchange restrictions on transferring funds out of China; no dividends declared or paid to Planet Green from subsidiaries.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 8 filings
πΊπΈ More from United States
View all βMarch 26, 2026
US Pre-Market SEC Filings Roundup β March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals β March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) β March 25, 2026
New Drug Approvals (Original)